125 related articles for article (PubMed ID: 30376884)
1. EPURE Transplant (Eplerenone in Patients Undergoing Renal Transplant) study: study protocol for a randomized controlled trial.
Girerd S; Frimat L; Ducloux D; Le Meur Y; Mariat C; Moulin B; Mousson C; Rieu P; Dali-Youcef N; Merckle L; Lepage X; Rossignol P; Girerd N; Jaisser F
Trials; 2018 Oct; 19(1):595. PubMed ID: 30376884
[TBL] [Abstract][Full Text] [Related]
2. Potassium canrenoate in brain-dead organ donors: a randomised controlled clinical trial protocol (CANREO-PMO).
Belarif L; Girerd S; Jaisser F; Lepage X; Merckle L; Duarte K; Girerd N; Guerci P
BMJ Open; 2023 Oct; 13(10):e073831. PubMed ID: 37821131
[TBL] [Abstract][Full Text] [Related]
3. PRODIG (Prevention of new onset diabetes after transplantation by a short term treatment of Vildagliptin in the early renal post-transplant period) study: study protocol for a randomized controlled study.
Gaiffe E; Crepin T; Bamoulid J; Courivaud C; Büchler M; Cassuto E; Albano L; Chemouny JM; Choukroun G; Hazzan M; Kessler L; Legendre C; Le Meur Y; Ouali N; Thierry A; Anota A; Nerich V; Limat S; Bonnetain F; Vernerey D; Ducloux D
Trials; 2019 Jun; 20(1):375. PubMed ID: 31227028
[TBL] [Abstract][Full Text] [Related]
4. Tocilizumab in chronic active antibody-mediated rejection: rationale and protocol of an in-progress randomized controlled open-label multi-center trial (INTERCEPT study).
Streichart L; Felldin M; Ekberg J; Mjörnstedt L; Lindnér P; Lennerling A; Bröcker V; Mölne J; Holgersson J; Daenen K; Wennberg L; Lorant T; Baid-Agrawal S
Trials; 2024 Mar; 25(1):213. PubMed ID: 38519988
[TBL] [Abstract][Full Text] [Related]
5. Calcineurin Inhibitor in NEuRoloGically deceased donors to decrease kidney delayed graft function study: study protocol of the CINERGY Pilot randomised controlled trial.
D'Aragon F; Selzner M; Breau R; Masse MH; Lamontagne F; Masse M; Chassé M; Carrier FM; Cardinal H; Chaudhury P; Weiss M; Lauzier F; Turgeon AF; Frenette AJ; Bolduc B; Ducharme A; Lamarche C; Couture E; Holdsworth S; Bertholz L; Talbot H; Slessarev M; Luke P; Boyd JG; Shamseddin MK; Burns KEA; Zaltzman J; English S; Knoll G; Dhanani S; Healey A; Hanna S; Rochwerg B; Oczkowski SJW; Treleaven D; Meade M;
BMJ Open; 2024 Jun; 14(6):e086777. PubMed ID: 38871657
[TBL] [Abstract][Full Text] [Related]
6. Alkaline phosphatase to treat ischaemia-reperfusion injury in living-donor kidney transplantation: APhIRI I feasibility pilot study.
Steenvoorden TS; van Duin RE; Rood JAJ; Peters-Sengers H; Nurmohamed AS; Bemelman FJ; Vogt L; van der Heijden JW
Br J Clin Pharmacol; 2023 Dec; 89(12):3629-3636. PubMed ID: 37548047
[TBL] [Abstract][Full Text] [Related]
7. The addition of simvastatin administration to cold storage solution of explanted whole liver grafts for facing ischemia/reperfusion injury in an area with a low rate of deceased donation: a monocentric randomized controlled double-blinded phase 2 study.
Pagano D; Oliva E; Khouzam S; Tuzzolino F; Cintorino D; Li Petri S; di Francesco F; Ricotta C; Bonsignore P; Tropea A; Calamia S; Costanzo F; Luca A; Gruttadauria S
BMC Surg; 2018 Dec; 18(1):122. PubMed ID: 30587165
[TBL] [Abstract][Full Text] [Related]
8. Investigating the Impact of AI on Shared Decision-Making in Post-Kidney Transplant Care (PRIMA-AI): Protocol for a Randomized Controlled Trial.
Osmanodja B; Sassi Z; Eickmann S; Hansen CM; Roller R; Burchardt A; Samhammer D; Dabrock P; Möller S; Budde K; Herrmann A
JMIR Res Protoc; 2024 Apr; 13():e54857. PubMed ID: 38557315
[TBL] [Abstract][Full Text] [Related]
9. Effect of Spironolactone on Kidney Function in Kidney Transplant Recipients (the SPIREN trial): A Randomized Placebo-Controlled Clinical Trial.
Mortensen LA; Jespersen B; Helligsoe ASL; Tougaard B; Cibulskyte-Ninkovic D; Egfjord M; Boesby L; Marcussen N; Madsen K; Jensen BL; Petersen I; Bistrup C; Thiesson HC
Clin J Am Soc Nephrol; 2024 Jun; 19(6):755-766. PubMed ID: 38416033
[TBL] [Abstract][Full Text] [Related]
10. Intravenous Ascorbic Acid for the Prevention of Postreperfusion Syndrome in Orthotopic Liver Transplantation: Protocol for a Randomized Controlled Trial.
Gajate L; de la Hoz I; Espiño M; Martin Gonzalez MDC; Fernandez Martin C; Martín-Grande A; Parise Roux D; Pastor O; Villahoz J; Rodriguez-Gandía MÁ; Nuño Vazquez J
JMIR Res Protoc; 2023 Dec; 12():e50091. PubMed ID: 38100226
[TBL] [Abstract][Full Text] [Related]
11. The hepatocyte growth factor mimetic, ANG-3777, in kidney transplant recipients with delayed graft function: Results from a randomized phase 3 trial.
Vincenti F; Bromberg J; Kim J; Faravardeh A; Leca N; Alperovich G; Csomor PA; Aslam S; Neylan J
Am J Transplant; 2024 Feb; ():. PubMed ID: 38387622
[TBL] [Abstract][Full Text] [Related]
12. Fasting before living-kidney donation: effect on donor well-being and postoperative recovery: study protocol of a multicenter randomized controlled trial.
Oudmaijer CAJ; Minnee RC; Pol RA; van den Boogaard WMC; Komninos DSJ; van de Wetering J; van Heugten MH; Hoorn EJ; Sanders JSF; Hoeijmakers JHJ; Vermeij WP; IJzermans JNM
Trials; 2022 Jan; 23(1):18. PubMed ID: 34991694
[TBL] [Abstract][Full Text] [Related]
13. Prompt Thrombo-Inflammatory Response to Ischemia-Reperfusion Injury and Kidney Transplant Outcomes.
Strandberg G; Öberg CM; Blom AM; Slivca O; Berglund D; Segelmark M; Nilsson B; Biglarnia AR
Kidney Int Rep; 2023 Dec; 8(12):2592-2602. PubMed ID: 38106604
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Overview of Innovative Strategies in Preventing Renal Ischemia-reperfusion Injury: Insights from Bibliometric and In Silico Analyses.
Rysmakhanov MS; Zare A; Smagulov AS; Abenova NA; Mussin NM; Sultangereyev YB; Zhakiyev BS; Kuttymuratov GK; Haberal M; Jafari N; Baneshi H; Bakhshalizadeh S; Mahdipour M; Rahmanifar F; Tamadon A
Curr Pharm Des; 2024 Apr; ():. PubMed ID: 38676525
[TBL] [Abstract][Full Text] [Related]
15. A nationwide study of regional preference and graft survival of kidney transplantation in South Korea: patterns of centralization in the capital area.
Park JI; Jang Y; Park H; Pyun S; Cho HR; Park SJ
Ann Surg Treat Res; 2024 Jan; 106(1):11-18. PubMed ID: 38205095
[TBL] [Abstract][Full Text] [Related]
16. Interventions to Preserve Cognitive Functioning Among Older Kidney Transplant Recipients.
Chu NM; Segev D; McAdams-DeMarco MA
Curr Transplant Rep; 2020 Dec; 7(4):346-354. PubMed ID: 33777649
[TBL] [Abstract][Full Text] [Related]
17. Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medications.
Espay AJ; Guskey MT; Norton JC; Coate B; Vizcarra JA; Ballard C; Factor SA; Friedman JH; Lang AE; Larsen NJ; Andersson C; Fredericks D; Weintraub D
Mov Disord; 2018 Nov; 33(11):1769-1776. PubMed ID: 30387904
[TBL] [Abstract][Full Text] [Related]
18. Long-term safety and tolerability of valsartan in children aged 6 to 17 years with hypertension.
Lou-Meda R; Stiller B; Antonio ZL; Zielinska E; Yap HK; Kang HG; Tan M; Glazer RD; Valentin MA; Wang L
Pediatr Nephrol; 2019 Mar; 34(3):495-506. PubMed ID: 30397789
[TBL] [Abstract][Full Text] [Related]
19. Polyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the IMPROVE-IT trial.
Bonaca MP; Gutierrez JA; Cannon C; Giugliano R; Blazing M; Park JG; White J; Tershakovec A; Braunwald E
Lancet Diabetes Endocrinol; 2018 Dec; 6(12):934-943. PubMed ID: 30396865
[TBL] [Abstract][Full Text] [Related]
20. Patient Satisfaction and Clinical Outcomes with Budesonide plus Formoterol Spiromax for Asthma and Chronic Obstructive Pulmonary Disease: A Real-World, Observational Trial.
Gillissen A; Gessner C; Hechenbichler K; Herth FJF; Juenemann R; Kanniess F; Kardos P; Lommatzsch M; Schneidereit R; Windisch W
Respiration; 2019; 97(4):292-301. PubMed ID: 30391944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
